Table 1: Clinical information at admission.

n = 459

n (%) or Median [IQR]

 

n (%) or Median [IQR]

Demographics

Compromise Lung (Chest CT)

Male, age (y)

262 (57.0); 60.0

[45.0-72.0]

< 50%

351 (83.7)

Obesity BMI ≥ 30

148 (33.1)

 ≥ 50%

68 (16.2)

Comorbidity

Laboratory

Hypertension

214 (46.8)

Hemoglobin (12.0-15.5 g/dL)

13.7 [12.5-14.8]

Pulmonary disease (emphysema, COPD, asthma)

101 (22.1)

Leukocytes (> 5.000%/mm3)

286 (62.7)

Diabetes

99 (21.6)

Lymphocytes (900-2.900 mm3)

1.030 [755-1.370]

Chronic kidney disease

43 (9.4)

Platelets (150.000-450.000 mm3)

177.000

[140.000-225.000]

Cancer (last 5 y)

43 (9.4)

Creatinine (0.60-1.10 mg/dL)

0.95 [0.81-1.16]

Self-Reported Symptoms

C-reactive protein (> 8.0 mg/dL)

141 (33.6)

Fever

284 (63.5)

D-dimers (> 1.250 ng/mL FEU)

71 (17.5)

Cough

271 (60.6)

Lactate dehydrogenase (240-480)

554 [443-680]

Dyspnea

173 (38.7)

Total bilirubin (0.0-0.30 mg/dL)

0.38 [0.27-0.49]

Headache

130 (29.0)

Troponin (under 14 ng/L)

7.0 [5.0-13.0]

Muscle pain (myalgia)

117 (26.1)

BNP (up to 100 pg/mL)

33.0 [13.0-192.0]

Sore throat

90 (20.1)

IL-6 (range 1.5-7.0 pg/mL)

37.0 [9.4-61.0]

Fatigue

84 (18.7)

 

 

Coryza

75 (16.7)

 

 

Diarrhea

54 (12.0)

 

 

Nausea and Vomiting

53 (11.8)

 

 

Presence of up to 3 symptoms

251 (56.1)

 

 

Y: Year; BMI: Body mass index; COPD: Chronic obstructive pulmonary disease; CT: Computed tomography; BNP: Brain natriuretic peptide